Do analysts prefer TNDM or CNXU?

Tandem Diabetes Care presently has a consensus target price of $29.84, indicating a potential upside of 79.77%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, analysts clearly believe Tandem Diabetes Care is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 1 Sell rating(s) 10 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.48 Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, TNDM or CNXU?

Conexeu Sciences has lower revenue, but higher earnings than Tandem Diabetes Care. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tandem Diabetes Care $1.01B 1.12 -$204.71M -$1.40 N/A Conexeu Sciences N/A N/A N/A N/A N/A

Does the media refer more to TNDM or CNXU?

In the previous week, Tandem Diabetes Care had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Tandem Diabetes Care and 3 mentions for Conexeu Sciences. Tandem Diabetes Care's average media sentiment score of 0.67 beat Conexeu Sciences' score of 0.44 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CNXU or CNMD?

CONMED has a consensus price target of $39.50, suggesting a potential upside of 13.53%. Given CONMED's stronger consensus rating and higher probable upside, analysts plainly believe CONMED is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 CONMED 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86

Which has stronger valuation & earnings, CNXU or CNMD?

CONMED has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A CONMED $1.37B 0.76 $47.06M $1.77 19.66

Does the media refer more to CNXU or CNMD?

In the previous week, Conexeu Sciences had 2 more articles in the media than CONMED. MarketBeat recorded 3 mentions for Conexeu Sciences and 1 mentions for CONMED. Conexeu Sciences' average media sentiment score of 0.44 beat CONMED's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CONMED 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CNXU or AORT?

Artivion has a consensus target price of $46.17, suggesting a potential upside of 130.38%. Given Artivion's stronger consensus rating and higher probable upside, analysts clearly believe Artivion is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Artivion 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.75

Which has preferable valuation & earnings, CNXU or AORT?

Artivion has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Artivion $441.33M 2.20 $9.77M $0.24 83.50

Does the media prefer CNXU or AORT?

In the previous week, Artivion had 2 more articles in the media than Conexeu Sciences. MarketBeat recorded 5 mentions for Artivion and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.44 beat Artivion's score of 0.34 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Artivion 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend CNXU or AVR?

Anteris Technologies Global has a consensus target price of $16.00, indicating a potential upside of 74.86%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Anteris Technologies Global 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Which has higher valuation and earnings, CNXU or AVR?

Conexeu Sciences has higher earnings, but lower revenue than Anteris Technologies Global. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Anteris Technologies Global $1.91M 466.31 -$94.14M -$2.23 N/A

Does the media favor CNXU or AVR?

In the previous week, Anteris Technologies Global had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Anteris Technologies Global and 3 mentions for Conexeu Sciences. Anteris Technologies Global's average media sentiment score of 0.55 beat Conexeu Sciences' score of 0.44 indicating that Anteris Technologies Global is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Anteris Technologies Global 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CNXU or DRTS?

Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential upside of 27.92%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Alpha Tau Medical 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43

Which has higher earnings and valuation, CNXU or DRTS?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Alpha Tau Medical N/A N/A -$42.63M -$0.67 N/A

Is CNXU or DRTS more profitable?

Conexeu Sciences' return on equity of 0.00% beat Alpha Tau Medical's return on equity. Company Net Margins Return on Equity Return on Assets Conexeu Sciences N/A N/A N/A Alpha Tau Medical N/A -73.23% -52.90%

Does the media favor CNXU or DRTS?

In the previous week, Alpha Tau Medical had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Alpha Tau Medical and 3 mentions for Conexeu Sciences. Alpha Tau Medical's average media sentiment score of 0.54 beat Conexeu Sciences' score of 0.44 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Tau Medical 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Conexeu Sciences (CNXU) Competitors

$11.29 -0.84 (-6.92%)

Closing price 06/12/2026 04:00 PM Eastern

Extended Trading

$12.24 +0.96 (+8.46%)

As of 06/12/2026 07:45 PM Eastern

Compare

CNXU vs. TNDM, CNMD, AORT, AVR, and DRTS

Should you buy Conexeu Sciences stock or one of its competitors? MarketBeat compares Conexeu Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conexeu Sciences include Tandem Diabetes Care (TNDM), CONMED (CNMD), Artivion (AORT), Anteris Technologies Global (AVR), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.

How does Conexeu Sciences compare to Tandem Diabetes Care?

Tandem Diabetes Care (NASDAQ:TNDM) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

Tandem Diabetes Care presently has a consensus target price of $29.84, indicating a potential upside of 79.77%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, analysts clearly believe Tandem Diabetes Care is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tandem Diabetes Care	1 Sell rating(s)	10 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.48
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Conexeu Sciences has lower revenue, but higher earnings than Tandem Diabetes Care.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tandem Diabetes Care	$1.01B	1.12	-$204.71M	-$1.40	N/A
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Conexeu Sciences has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -9.20%. Conexeu Sciences' return on equity of 0.00% beat Tandem Diabetes Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%
Conexeu Sciences	N/A	N/A	N/A

In the previous week, Tandem Diabetes Care had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Tandem Diabetes Care and 3 mentions for Conexeu Sciences. Tandem Diabetes Care's average media sentiment score of 0.67 beat Conexeu Sciences' score of 0.44 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tandem Diabetes Care	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Tandem Diabetes Care beats Conexeu Sciences on 7 of the 10 factors compared between the two stocks.

How does Conexeu Sciences compare to CONMED?

Conexeu Sciences (NASDAQ:CNXU) and CONMED (NYSE:CNMD) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

CONMED has a consensus price target of $39.50, suggesting a potential upside of 13.53%. Given CONMED's stronger consensus rating and higher probable upside, analysts plainly believe CONMED is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
CONMED	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86

CONMED has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
CONMED	$1.37B	0.76	$47.06M	$1.77	19.66

In the previous week, Conexeu Sciences had 2 more articles in the media than CONMED. MarketBeat recorded 3 mentions for Conexeu Sciences and 1 mentions for CONMED. Conexeu Sciences' average media sentiment score of 0.44 beat CONMED's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CONMED	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CONMED has a net margin of 4.00% compared to Conexeu Sciences' net margin of 0.00%. CONMED's return on equity of 13.84% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
CONMED	4.00%	13.84%	6.05%

Summary

CONMED beats Conexeu Sciences on 6 of the 8 factors compared between the two stocks.

How does Conexeu Sciences compare to Artivion?

Conexeu Sciences (NASDAQ:CNXU) and Artivion (NYSE:AORT) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

In the previous week, Artivion had 2 more articles in the media than Conexeu Sciences. MarketBeat recorded 5 mentions for Artivion and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.44 beat Artivion's score of 0.34 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Artivion	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Artivion has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Artivion	$441.33M	2.20	$9.77M	$0.24	83.50

Artivion has a net margin of 2.55% compared to Conexeu Sciences' net margin of 0.00%. Artivion's return on equity of 7.15% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Artivion	2.55%	7.15%	3.63%

Artivion has a consensus target price of $46.17, suggesting a potential upside of 130.38%. Given Artivion's stronger consensus rating and higher probable upside, analysts clearly believe Artivion is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75

86.4% of Artivion shares are held by institutional investors. 6.3% of Artivion shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Artivion beats Conexeu Sciences on 10 of the 11 factors compared between the two stocks.

How does Conexeu Sciences compare to Anteris Technologies Global?

Conexeu Sciences (NASDAQ:CNXU) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, risk, institutional ownership and dividends.

In the previous week, Anteris Technologies Global had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Anteris Technologies Global and 3 mentions for Conexeu Sciences. Anteris Technologies Global's average media sentiment score of 0.55 beat Conexeu Sciences' score of 0.44 indicating that Anteris Technologies Global is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Conexeu Sciences has higher earnings, but lower revenue than Anteris Technologies Global.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Anteris Technologies Global	$1.91M	466.31	-$94.14M	-$2.23	N/A

Anteris Technologies Global has a consensus target price of $16.00, indicating a potential upside of 74.86%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, analysts plainly believe Anteris Technologies Global is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Conexeu Sciences has a net margin of 0.00% compared to Anteris Technologies Global's net margin of -5,148.78%. Conexeu Sciences' return on equity of 0.00% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Summary

Anteris Technologies Global beats Conexeu Sciences on 6 of the 9 factors compared between the two stocks.

How does Conexeu Sciences compare to Alpha Tau Medical?

Conexeu Sciences (NASDAQ:CNXU) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential upside of 27.92%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, analysts clearly believe Alpha Tau Medical is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Conexeu Sciences' return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Alpha Tau Medical	N/A	-73.23%	-52.90%

2.7% of Alpha Tau Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 3 more articles in the media than Conexeu Sciences. MarketBeat recorded 6 mentions for Alpha Tau Medical and 3 mentions for Conexeu Sciences. Alpha Tau Medical's average media sentiment score of 0.54 beat Conexeu Sciences' score of 0.44 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Tau Medical	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Alpha Tau Medical beats Conexeu Sciences on 7 of the 9 factors compared between the two stocks.

Get Conexeu Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNXU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNXU vs. The Competition

Export

Metric	Conexeu Sciences	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$285.30M	$2.81B	$4.94B	$12.02B
Dividend Yield	N/A	N/A	9.91%	5.61%
P/E Ratio	N/A	12.29	22.22	24.42
Price / Sales	N/A	334.02	164.60	109.73
Price / Cash	N/A	8.13	42.20	55.64
Price / Book	N/A	5.47	27.17	6.79
Net Income	N/A	$7.39M	$118.48M	$337.66M
7 Day Performance	-25.92%	-1.57%	0.66%	2.56%
1 Month Performance	N/A	-3.66%	-0.90%	2.03%
1 Year Performance	N/A	4.32%	14.01%	30.31%

Conexeu Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNXU Conexeu Sciences	N/A	$11.29 -6.9%	N/A	N/A	$285.30M	N/A	N/A	4	Short Interest Increase
TNDM Tandem Diabetes Care	2.6526 of 5 stars	$16.60 +5.1%	$29.84 +79.8%	-20.7%	$1.08B	$1.01B	N/A	2,500	Analyst Downgrade
CNMD CONMED	2.1948 of 5 stars	$34.79 +1.1%	$39.50 +13.5%	-36.5%	$1.04B	$1.37B	19.66	3,900
AORT Artivion	4.312 of 5 stars	$20.04 -2.7%	$46.17 +130.4%	-30.3%	$999.99M	$441.33M	83.50	1,800
AVR Anteris Technologies Global	3.7215 of 5 stars	$9.15 -1.7%	$16.00 +74.9%	+87.9%	$906.26M	$1.91M	N/A	138

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CNXU) was last updated on 6/13/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Conexeu Sciences (CNXU) Competitors

CNXU vs. TNDM, CNMD, AORT, AVR, and DRTS

How does Conexeu Sciences compare to Tandem Diabetes Care?

Summary

How does Conexeu Sciences compare to CONMED?

Summary

How does Conexeu Sciences compare to Artivion?

Summary

How does Conexeu Sciences compare to Anteris Technologies Global?

Summary

How does Conexeu Sciences compare to Alpha Tau Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Conexeu Sciences (CNXU) Competitors

CNXU vs. TNDM, CNMD, AORT, AVR, and DRTS

How does Conexeu Sciences compare to Tandem Diabetes Care?

Do analysts prefer TNDM or CNXU?

Which has higher earnings and valuation, TNDM or CNXU?

Is TNDM or CNXU more profitable?

Does the media refer more to TNDM or CNXU?

Summary

How does Conexeu Sciences compare to CONMED?

Do analysts prefer CNXU or CNMD?

Which has stronger valuation & earnings, CNXU or CNMD?

Does the media refer more to CNXU or CNMD?

Is CNXU or CNMD more profitable?

Summary

How does Conexeu Sciences compare to Artivion?

Does the media prefer CNXU or AORT?

Which has preferable valuation & earnings, CNXU or AORT?

Is CNXU or AORT more profitable?

Do analysts prefer CNXU or AORT?

Do institutionals and insiders have more ownership in CNXU or AORT?

Summary

How does Conexeu Sciences compare to Anteris Technologies Global?

Does the media favor CNXU or AVR?

Which has higher valuation and earnings, CNXU or AVR?

Do analysts recommend CNXU or AVR?

Is CNXU or AVR more profitable?

Summary

How does Conexeu Sciences compare to Alpha Tau Medical?

Which has higher earnings and valuation, CNXU or DRTS?

Do analysts recommend CNXU or DRTS?

Is CNXU or DRTS more profitable?

Do insiders and institutionals have more ownership in CNXU or DRTS?

Does the media favor CNXU or DRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNXU vs. The Competition

Conexeu Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools